is phentermine a glp-1 receptor agonist vs. Injections: What's the Real Difference? Frontiers | GLP−1 receptor agonists
Description
As amylin and GLP-1 target different populations of neurons in the DVC 20 , this suggests that combination drug therapies affecting both systems may provide a greater magnitude and sustainable degree of weight loss compared to monotherapies due to a reduced likelihood of tachyphylaxis 21,22,23
[DOI] [PMC free article] [PubMed] [Google Scholar] 757.McKay N.J., Galante D.L., Daniels D
Daily administration would produce accumulating plasma levels far beyond the studied range, dramatically increasing side effects without proportional benefit
Pharmacol Rep
